What's a Realistic Retirement Age?
Farmers Hit the Jackpot in Kansas Oil Boom
Bristol-Myers Squibb (BMY - option chain) shares are rising today after the release of a study which shows that an experimental blood-thinning drug co-produced by BMY and Pfizer (PFE) cut the rate of strokes among people with abnormal heartbeats by more than 50% versus aspirin. If you think that the stock won't fall by too much in the coming months, then now could be a good time to look at a bullish hedged trade on BMY.BMY opened this morning at $26.11. So far today the stock has hit a low of $26.00 and a high of $26.34. As of 12:25, BMY is trading at $26.20 up 0.35 (1.3%). The chart for BMY looks bullish and S&P gives BMY a positive 4 STARS (out of 5) buy ranking.
Goldman Earnings Sink After Buffett Dividend
Johnson & Johnson's Income Falls 23%
Burberry Shares Leap on Sales Update
